Technical Data on Top Gainers -- Research on Cisco Systems, Synthetic Biologics, Ur-Energy, and Gentiva Health Services

LONDON, May 16, 2014 /PRNewswire/ --

The US markets saw a negative sentiment on Thursday, May 15, 2014, with the NASDAQ Composite closing at 4,069.29, down 0.76%, the Dow Jones Industrial Average ending the session 1.01% lower to close the day at 16,446.81, and the S&P 500 falling 0.94% to finish the trading session at 1,870.85. The losses were broad based as nine out of ten sectors ended the session in negative. During the session, losses in the Materials, Energy and Financials sectors negatively impacted the broader market, while some positive momentum was observed in the Telecommunication Services sector. A number of stocks saw large movements, including Cisco Systems Inc. (NASDAQ: CSCO), Synthetic Biologics Inc. (NYSE MKT: SYN), Ur-Energy Inc. (NYSE MKT: URG) and Gentiva Health Services Inc. (NASDAQ: GTIV). Free technical research on CSCO, SYN, URG and GTIV can be downloaded upon signing up at:

http://www.investor-edge.com/2629-register

Cisco Systems Inc.'s stock finished Thursday's session 6.01% higher at $24.18. A total of 120.80 million shares were traded, which was much above its three months average volume of 38.33 million shares. The stock vacillated between $24.12 and $24.69 during the session. Over the last one month and previous three months, Cisco Systems Inc.'s shares have advanced 5.64% and 7.18%, respectively. Additionally, from the year's start, the company's stock has gained an upside of 7.80%. The S&P 500 Information Technology Sector Index mapped a loss of 0.79% during the trading session, while the index charted up 1.55% in the last one month. The company's shares are trading above their 50-day and 200-day moving averages. Moreover, the stock's 200-day moving average of $22.79 is greater than its 50-day moving average of $22.56. Cisco Systems Inc.'s stock traded at a PE ratio of 14.40 and has a Relative Strength Index (RSI) of 47.77. On May 14, 2014, Cisco Systems Inc. announced its Q3 FY 2014 financial results (period ended April 26, 2014) net income of $2.2 billion, or $0.42 per diluted share. Sign up today to read free research on CSCO at:

http://www.investor-edge.com/2629-CSCO-16May2014.pdf

On Thursday, shares in Synthetic Biologics Inc. fluctuated between $1.25 and $1.48 before ending the session 25.86% higher at $1.46. The stock reported a trading volume of 3.23 million shares, above its three months average volume of 1.86 million shares. Synthetic Biologics Inc.'s shares have surged 12.31% in the previous three trading sessions, whereas the stock has declined 41.13% in the last one month and 4.58% on YTD basis. The stock is trading below its 50-day and 200-day moving averages of $2.44 and $1.85, respectively. Moreover, shares of Synthetic Biologics Inc. have an RSI of 27.68. On the same day, Synthetic Biologics Inc. announced its Q1 FY 2014 financial results (period ended March 31, 2014). For Q1 FY 2014, the company reported net loss attributable to Synthetic Biologics Inc. of $3.84 million, or $0.07 per diluted share. Sign up today to read free research on SYN at:

http://www.investor-edge.com/2629-SYN-16May2014.pdf

Ur-Energy Inc.'s stock surged 9.90%, closing the day at $1.11. The stock recorded a trading volume of 1.78 million shares, above its three months average volume of 1.21 million shares. The stock oscillated between $1.02 and $1.13 during the trading session. Over the last three trading sessions, Ur-Energy Inc.'s shares have gained 4.72%. However, the stock has lost 17.16% in the last one month and 19.57% since the start of this year. The S&P 500 Energy Sector Index recorded a loss of 1.31% during the trading session, while the index has gained 8.92% in the last previous three months. The stock is trading below its 50-day and 200-day moving averages. Ur-Energy Inc.'s 50-day moving average of $1.45 is above its 200-day moving average of $1.27. Additionally, the stock has an RSI of 28.28. Sign up today to read free research on URG at:

http://www.investor-edge.com/2629-URG-16May2014.pdf

On Thursday, shares in Gentiva Health Services Inc. recorded a trading volume of 6.64 million shares, much above its three months average volume of 0.37 million shares. The stock ended the day at $13.83, which was 61.94% above its previous day's closing price of $8.54, and registered an intraday range of $13.56 and $14.50. Gentiva Health Services Inc.'s shares have rallied 56.80% in the previous three trading sessions, 81.50% in the last one month, and 11.44% on YTD basis. The S&P 500 Health Care Sector Index mapped a loss of 0.84% during the previous three trading session and the index has fallen by 0.51% in the last three months. Gentiva Health Services Inc.'s stock is trading above its 50-day and 200-day moving averages of $8.47 and $10.96, respectively. Furthermore, shares of the company have an RSI of 53.99. Sign up today to read free research on GTIV at:

http://www.investor-edge.com/2629-GTIV-16May2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED